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Introduction
In recent years, an intense debate has taken place about the value of Randomized Controlled Trials (RCTs). 1 Most notably in development economics, RCTs have assumed a dominating role. The striking advantage of RCTs is that they overcome selfselection into treatment and thus their internal validity is indisputably high. This merit is sometimes contrasted with shortcomings in external validity (BASU 2014; DEATON AND CARTWRIGHT 2016) . Critics state that establishing external validity is more difficult for RCTs than for studies based on observational data (DEHEJIA 2015 , MULLER 2015 , MOFFIT 2004 , PRITCHETT AND SANDEFUR 2015 , ROE AND JUST 2009 , and TEMPLE 2010 . This is particularly true for RCTs in the development context that tend to be implemented at smaller scale and in a specific locality. Scaling an intervention is likely to change the treatment effects, because the scaled program is typically implemented by resource-constrained governments, while the original RCT is often implemented by Economics. In total, we identified 54 RCT-based papers in these journals.
Since there is no uniform definition of external validity and its hazards in the literature, in a first step we establish a theoretical framework deducing the assumptions required to transfer findings from an RCT to another policy population. We do this based on a model from the philosophical literature on the probabilistic theory of causality provided by CARTWRIGHT (2010) and based on a seminal contribution to the economics literature, the toolkit for the implementation of RCTs by DUFLO, GLENNERSTER, AND KREMER (2008) . We identify four hazards to external validity: i) Hawthorne and John Henry Effects, ii) general equilibrium effects, iii) specific sample problems, and iv) problems that occur when the treatment in the RCT is provided with special care compared to how it would be implemented under real-world conditions.
As a second step, we scrutinize the reviewed papers with regard to how they deal with the four external validity dimensions and whether required assumptions are discussed. Along the lines of these hazards we formulated seven questions, then read all 54 papers carefully and asked each of them these seven questions. All questions can be objectively answered by 'yes' or 'no'; no subjective rating is involved.
External validity is not necessary in some cases. For example, when RCTs are used for accountability reasons by a donor or a government, the results are only interpreted within the evaluated population. Yet, as soon as these findings are used to inform policy elsewhere or at larger scale, external validity becomes a pivotal element.
Moreover, test-of-a-theory or proof of concept RCTs that set out to disprove a general theoretical proposition speak for themselves and do not need to establish external validity (DEATON AND CARTWRIGHT 2016). However, in academic research most RCTs presumably intend to inform policy and, as we will also confirm in the review, the vast majority of included papers appear to generalize findings from the study population to a different policy population. 2 Indeed, RCT proponents in the development community advocate in favor of RCTs in order to create "global public goods" that "can offer reliable guidance to international organizations, governments, donors, and NGOs beyond national borders" (DUFLO, GLENNERSTER AND KREMER 2008, p. 93 In the remainder of the paper we first present the theoretical framework and establish the four hazards to external validity (Section 1), before the methodological approach and the seven questions are discussed in Section 2. The results are presented in Section 3 and discussed in Section 4. Section 5 provides an overview on existing remedies for external validity problems and ways to deal with them in practice. Section 6 concludes.
Theoretical Background and Definition of External Validity

Theoretical Framework
The understanding of what external validity exactly is and how it might be threatened is not clearly defined in the literature. What we are interested in here is the degree to which an internally valid finding obtained in an RCT is relevant for policy makers who want to implement the same intervention in a different policy population.
CARTWRIGHT (2010, p. 60) defines external validity in a way that is similar to the understanding conveyed in DUFLO, GLENNERSTER AND KREMER (2008, DGK in the following): "External validity has to do with whether the result that is established in the study will be true elsewhere." Cartwright provides a model based on the probabilistic theory of causality. Using this model we identify the assumptions that have to be made when transferring the results from an RCT to what a policy maker can expect if she scales the intervention under real-world conditions. Suppose we are interested in whether a policy intervention C affects a certain outcome E, we can state that C causes E if where Ki describes the environment and intervention particularities under which the observation is made. Assume this causal relationship was observed in population A and we want to transfer it to a situation in which C is introduced to another population A'. In this case, Cartwright points out that those observations Ki have to be identical in both populations A and A' as soon as they interfere with the treatment effect. More specifically, Cartwright formulates the following assumptions that are required:
A needs to be a representative sample of A'
(ii) C is introduced in A' as it was in the experiment in A (iii) The introduction leaves the causal structure in A' unchanged.
In the following, we use the language that is widely used in the economics literature and refer to the toolkit for the implementation of RCTs by DGK (2008 Organizations that agree to cooperate with researchers on an RCT can be expected to be different compared to those that do not, for example because their staff are more motivated. This difference could translate into a higher general effectiveness.
Therefore, the effectiveness observed in RCTs is probably higher than it will be when the evaluated program is scaled to those organizations that did not cooperate with researchers at first.
The third identified hazard arises from potential general equilibrium effects (GEE). 6 Typically, such GEE only become noticeable if the program is scaled to a broader population or extended to a longer term. In the stylized cash transfer example provided above, GEE occur if not only a small number of people but many villagers receive the transfer payment. In this scaled version of the intervention, some of the products that young male villagers want to buy become scarcer and, thus, more expensive. This also illustrates that GEE can affect non-treated villagers, as prices increase for them as well. Moreover, in the longer term if the cash transfer program is implemented permanently, certain norms and attitudes towards labor supply or educational investment might change. 7 This example indicates that GEE in their entirety are difficult to capture. The severity of GEE, though, depends on some parameters like the regional coverage of the RCT, the time horizon of the measurements, and the impact indicators the study looks at.
Very small-scale RCTs or those that measure outcomes after a few months only are unlikely to portray the change in norms and beliefs that the intervention might entail.
Furthermore, especially market based outcomes like wages or employment status will certainly be affected by adjustments in the general equilibrium if an intervention is scaled and implemented over many years. As a matter of course, it is beyond the scope of most studies to comprehensively account for such GEE and RCTs that cleanly identify partial equilibrium effects can still be informative for policy. A profound discussion of GEE relevant features is nonetheless necessary to avoid the ill-advised interpretation of results. Note that GEE are not particular to RCTs and, all else equal, the generalizability of the results from observational studies is also exposed by potential GEE. Many RCTs, in particular in developing country contexts, are however limited to a specific region, a relatively small sample size, and short monitoring horizon and are thus more prone to GEE than country-wide representative panel-data based observational studies.
In a similar vein, the fourth hazard to external validity, the specific sample problem, is not particular to RCTs but might be more pronounced in this setting. The problem occurs if the study population is different from the policy population in which the intervention will be brought to scale. Taking the cash transfer example, the treatment effect for young male adults can be expected to be different if the cash transfer is given to young female adults in the same village or to young male adults in a different part of the country.
In Section 2.2, these hazards to external validity are translated into objective questions to be asked during the systematic review of published RCTs.
Methods and Data
Review approach
We We scrutinized all issues in the period; all papers that mention either the terms "field experiment", "randomized controlled trials" or "experimental evidence" in either the title or the abstract or that indicated in the abstract or the title that a policy intervention was randomly introduced were examined further. We excluded those papers that examine interventions in an OECD member country. 8 In total, 73 papers were initially identified. Our focus is on policy evaluation and we therefore excluded mere test-ofa-theory papers. 9 In most cases, the demarcation was very obvious and we subsequently excluded 19 papers. In total, we found 54 papers based on an RCT to evaluate a certain policy intervention in a developing country. 10 The distribution across journals is uneven with the vast majority being published in the American Economic Journal: Applied Economics, the American Economic Review and the Quarterly Journal of Economics (see Figure 1) . We read all 54 papers carefully (including the online appendix) and each paper was asked seven objective yes/no-questions. An additional filter question addresses whether the paper has the ambition to generalize. This is necessary, because it is sometimes argued that not all RCTs intend to generate generalizable results and are rather designed to test a theoretical concept. In fact, 96 percent of included papers do generalize (see next section for details on the coding of this question). This is no surprise, since on purpose we excluded test-of-a-theory papers and focused on policy evaluations. The remaining seven questions all address the four hazards to external validity outlined in Section 1 and examine whether the ´credibility-enhancing arguments´ (RODRIK 2009) are provided to underpin the plausibility of external validity. Appendix A in the Annex shows the answers to the seven questions for all surveyed papers individually. In general, we answered the questions conservatively,
i.e. when in doubt we answered in favor of the paper. We abstained from applying subjective ratings in order to avoid room for arbitrariness. A simple report on each paper documents the answers to the seven questions and the quote from the paper underlying the respective answer. We sent these reports out to the lead authors of the included papers and asked them to review our answers for their paper(s). 12 For 36 of the 54 papers we received feedback, based on which we changed an answer from 'no'
to 'yes' in 9 cases (out of 378 questions and answers in total). The comments we received from the authors are included in the reports, if necessary followed by a short reply. The revised reports were sent again to the authors for their information and can be found in the online appendix to this paper.
Seven questions
To elicit the extent the paper accounts for Hawthorne and John Henry effects we first asked the following objective questions:
1. Does the paper explicitly say whether participants are aware (or not) of being part of an experiment or a study?
The third hazard is what DGK call the specific sample problem and is addressed by Question 5:
5. Does the paper explicitly discuss the policy population (to which the findings are generalized) or potential restrictions in generalizing results from the study population?
We applied this question only to those papers that explicitly generalize beyond the study population (see filter question below and in Section 2.1). As soon as a paper discusses the study population vis-à-vis the policy population, we answered the question with 'yes', irrespective of our personal judgement on whether we deem the statement to be plausible and the discussion to be comprehensive.
The fourth hazard, special care, is accounted for by two questions:
6. Does the paper discuss particularities of how the randomized treatment was provided in demarcation to a (potential) real-world intervention?
As soon as the paper makes a statement on the design of the treatment compared to the potential real-world treatment, we answered the question with 'yes', again irrespective of our personal judgement of whether we deem the statement to be plausible and comprehensive.
In addition, to account for the concern that RCTs implemented by NGOs or researchers themselves might be more effective than scaled programs implemented by, for example, government agencies, we elicit:
7. Who is the implementation partner of the RCT?
The specific wording of the additional filter question is "Does the paper generalize beyond the study population?". Our coding of this question certainly leaves more room for ambiguity than the coding for the previous objective questions. We therefore answered this additional question by a 'yes' as soon as the paper makes any generalizing statements (most papers do that in the conclusions) that a mere test-of-atheory would not make. 14 Note that in this question we do not assess the degree to which the paper generalizes (which in fact varies considerably), but only if it generalizes at all. Table 1 shows the results for the seven questions asked to every paper. As noted above, Only 46 percent of all papers discuss how effects might change in the longer term and whether some sort of adjustments might occur (Question 4). Here, it is important to note that around 65 percent of the reviewed papers examine impacts less than two years after the randomized treatment; on average impacts are evaluated 17 months after the treatment (not shown in the table). While this is in most cases probably inevitable for practical reasons, a discussion of whether treatment effects might change in the long run, for example based on qualitative evidence or theoretical considerations, would be desirable. Note that most of the papers that do discuss longterm effects are those that in fact look at such long-term effects. In other words, only a small minority of papers that only look at very short term effects provides a discussion of potential changes in the long run.
Results
Likewise, potential changes in treatment effects in case the intervention is scaled are hardly discussed (Question 3, 44 percent of papers); 35 percent of the papers do not mention GEE related issues at all, i.e. received a 'no' for Question 3 and 4 (not shown in Table 1 ). The best score is achieved for the specific sample problem: 77 percent of papers discuss the policy population or potential restrictions to generalizability. As the results for Question 6 show, only 20 percent discuss the special care problem.
This finding has to be interpreted in the light of the result for Question 7 in Figure 3 :
More than 60 percent of RCTs were implemented by either the researchers themselves or an NGO. For these cases, a discussion of the special care issue is particularly necessary. The remaining RCTs were implemented by either a large firm or a governmental body -which may better resemble a business-as-usual situation. 15
Figure 3: Implementation partners of published RCTs (54 studies included in total, frequencies in bold)
Note: "Regional public authority" refers to interventions implemented by regional governmental entities on the local level. Table A1 in the online appendix provides a further decomposition of the results presented in Table 1 we do not observe major differences. Overall, there is no clear trend towards a systematic and transparent discussion of external validity issues.
Discussion
Our interpretation of the results presented in the previous section may be controversial. In this section we consider some of the comments and arguments that have been put forward during the genesis of the paper. We would like to emphasize that for the sake of transparency and rigor we only used objective questions and abstained from qualitative ratings. While we acknowledge that this approach does not do justice to every single paper, we argue that the overall pattern we obtain is a fair representation of how seriously external validity issues are taken in the publication of RCTs. Also note again that we answered all questions very conservatively.
To summarize the results, we find that many published RCTs do not provide a comprehensive presentation of how the experiment was implemented. 16 More than half of the papers do not even mention whether the participants in the experiment are aware of being randomized -which is crucial to assess whether Hawthorne-or JohnHenry-effects could co-determine the outcomes in the RCT. It is true that in some cases it is obvious whether participants were aware of an experiment or not, but in most cases it is indeed ambiguous. In addition, even in case it is obvious, it is important to know what exactly participants were told and thus, a discussion of how vulnerable the evaluated indicators are to Hawthorne-like distortions would be desirable.
Furthermore, our results show that potential general equilibrium effects are only rarely addressed. This is above all worrisome in case outcomes involve price changes reveal potential special care problems and acknowledge that a scaled program might be less effective. 17 We abstain from giving explicit bad practice examples (for obvious reasons), but indeed some studies are, we believe, negligently silent about certain hazards in spite of very obvious problems. In a minority of cases this is even exacerbated by a very ambitious and broad generalization of the findings.
Some commentators argued that RCTs which test a theory are not necessarily meant to be generalized. Yet, by design we concentrate our review on papers that evaluate a certain policy and hence the vast majority of papers included in this review do generalize results. In addition, a mere test-of-a-theory paper should in our views communicate this clearly to avoid misleading interpretations by policy makers and the public.
This is related to the question whether in fact all papers are supposed to address all external validity dimensions included in our review. Our answer is yes, at least for policy evaluations that generalize their findings. One might argue that some of the reviewed papers are completely immune to a certain external validity hazard, but the cost of briefly establishing this immunity is negligible (see next Section).
Potential Remedies
In an ideal world, external validity would be established by replications in many different populations and using different designs that vary the parameters which potentially codetermine the results. Systematic reviews can then compile the collective information in order to identify patterns in the effectiveness that eventually inform policy. This is the mission of organizations like the Campbell foundation, the Cochrane foundation as well as the International Initiative for Impact Evaluation (3ie) and systematic reviews have indeed been done in a few cases 18 . In a similar vein, BANERJEE process. Yet, it is evident that this approach as well as systematic reviews require a massive collective research endeavor that will take many years and that is probably not feasible in all cases.
It is this paper's stance that in the meantime individual RCTs have to establish external validity, reveal limitations, and discuss implications for transferability openly. To achieve this goal, the first and most obvious step is to include a systematic reporting for example. Some design features could be retrieved already in the pre-analysis plan, but at the latest during the peer-review process the checklist should be included and reviewed. Such a checklist ensures that the reader has all information at hand allowing her to make an informed judgement on the transferability of the results. Moreover, potential weaknesses should be disclosed, thereby automatically entailing a qualitative discussion to establish or restrict the study's external validity. In addition, a mandatory checklist also creates incentives to take external validity issues already into account in the study's design phase.
Next to more transparence in the publication of RCTs, a few instruments exist to deal with external validity hazards -some of which are post hoc, some can be incorporated in the design of the study. For Hawthorne and John Henry effects, the most obvious solution is not to inform the participants about the randomization, which of course hinges upon the study design. Such an approach resembles to what LEVITT AND LIST (2009) refer to as a `natural field experiment´. In some set-ups people have to be informed, either because randomization is obvious or for ethical reasons. The standard remedy in medical research -assigning a third group to a placebo treatment -is not possible in most experiments in social sciences. ALDASHEV et al. (2017) emphasize that the assignment procedure that is used to randomly assign participants into treatment and control groups affects the size of the bias considerably. They suggest that a public randomization reduces bias as compared to a non-transparent private randomization.
Accounting for general equilibrium effects comprehensively is impossible in most cases, since all types of macro-economic adjustments can hardly be captured in a micro-economic study. In order to evaluate what eventually happens in the general equilibrium one would have to resort to computable general equilibrium (CGE) models. Indeed, there are ambitions to plug the results of RCT based evaluations into CGE models as it is done with observational data in COADY AND HARRIS (2004).
The seminal work on GEE so far tests for the existence of at least selected macro- implementation capability is demonstrably low for logistical tasks, let alone for complex ones". Hence, the higher the complexity of an intervention, the more implementation capability becomes a bottleneck and, to use our wording, the more special care puts external validity at risk. Woolcock's position is that for complex 24 interventions -so the vast majority of policy interventions -generalizing is a "decidedly high-uncertainty undertaking". He suggests including qualitative case studies into these deliberations.
Conclusion
In theory, there seems to be a consensus among empirical researchers that establishing external validity of a policy evaluation is as important as establishing its internal validity. Against this background, this paper has systematically reviewed published
RCTs to examine whether external validity concerns are addressed. Our findings suggest that external validity is often neglected and does not play the important role that it is associated with in review papers and the general academic debate.
In a nutshell, our sole claim is that papers should discuss the extent to which the different hazards to external validity apply. We call for dedicating the same devotion to establishing external validity as is done to establishing internal validity. This thinking implies that papers published in top academic journals are not only targeted to the research community, but also to a policy-oriented audience (including decisionmakers and journalists). This audience, in particular, needs all the information necessary to make informed judgements on the extent to which the findings are transferable to other regions and non-experimental business-as-usual settings. A more transparent reporting would also lead to a situation in which more generalizable RCTs receive more attention than those that were implemented under heavily controlled circumstances or in a very specific region only.
It would be desirable if the peer review process at economics journals explicitly scrutinized design features of RCTs that are relevant for generalization. As a starting point, this does not need to be more than a checklist and short statements to be included in an electronic appendix. The logic is that only if researchers know already at the beginning of a study that they will need to provide such checklists and discussions, they will have clear incentives to account for external validity issues in the study design. Otherwise, external validity degenerates to a nice-to-have feature 25 that researchers account for voluntarily and for intrinsic reasons. These internal incentives will probably work in many cases. But given the trade-offs we all face during the laborious implementation of studies it is almost certain that external validity will often be sacrificed for other features to which the peer-review process currently pays more attention. 14 We coded this question by 'yes' in case the paper derives explicit policy recommendations for other regions or countries and in case it makes statements like "our results suggest that this policy works/does not work" or "our results generalize to". 15 It could of course be argued that NGOs can also be considered as "business-as-usual", since many real-world interventions, especially in developing countries, are implemented by NGOs. However, for most of the 20 RCTs that were implemented by an NGO, the cooperating NGO was a rather small one and regionally limited in its activities. Thus, bringing the intervention to scale would be the task of either the government or a larger NGO with potential implications for the efficacy of the intervention. 16 This finding is in line with Eble et al. (2017) who review RCTs published between 2001 and 2011 for how they deal with different sorts of biases (also covering Hawthorne effects). 17 Details on these examples can be found in the review report on the respective paper in the Online Appendix.
18 Examples of systematic reviews are ACHARYA ET AL (2012) 
